Heidi Glosli

  • Senior scientist and project leader MD, PhD
  • +47 23 07 45 93 or +47 99 57 11 83
 

Author network for Heidi Glosli by COREMINE medical


Publications 2019

Skou AS, Olsen SØ, Nielsen LH, Glosli H, Jahnukainen K, Jarfelt M, Jónmundsson GK, Malmros J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (NOPHO) (2019)
Hearing Status in Survivors of Childhood Acute Myeloid Leukemia Treated With Chemotherapy Only: A NOPHO-AML Study
J Pediatr Hematol Oncol, 41 (1), e12-e17
DOI 10.1097/MPH.0000000000001302, PubMed 30550508

Publications 2018

Bisogno G, Jenney M, Bergeron C, Gallego Melcón S, Ferrari A, Oberlin O, Carli M, Stevens M, Kelsey A, De Paoli A, Gaze MN, Martelli H, Devalck C, Merks JH, Ben-Arush M, Glosli H, Chisholm J, Orbach D, Minard-Colin V, De Salvo GL, European paediatric Soft tissue sarcoma Study Group (2018)
Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial
Lancet Oncol, 19 (8), 1061-1071
DOI 10.1016/S1470-2045(18)30337-1, PubMed 29941280

Gallego S, Zanetti I, Orbach D, Ranchère D, Shipley J, Zin A, Bergeron C, de Salvo GL, Chisholm J, Ferrari A, Jenney M, Mandeville HC, Rogers T, Merks JHM, Mudry P, Glosli H, Milano GM, Ferman S, Bisogno G, European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) (2018)
Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)
Cancer, 124 (15), 3201-3209
DOI 10.1002/cncr.31553, PubMed 29797665

Wilhelmsson M, Glosli H, Ifversen M, Abrahamsson J, Winiarski J, Jahnukainen K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (NOPHO) (2018)
Long-term health outcomes in survivors of childhood AML treated with allogeneic HSCT: a NOPHO-AML Study
Bone Marrow Transplant (in press)
DOI 10.1038/s41409-018-0337-8, PubMed 30242226

Publications 2017

Vaarwerk B, van der Lee JH, Breunis WB, Orbach D, Chisholm JC, Cozic N, Jenney M, van Rijn RR, McHugh K, Gallego S, Glosli H, Devalck C, Gaze MN, Kelsey A, Bergeron C, Stevens MCG, Oberlin O, Minard-Colin V, Merks JHM (2017)
Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study
Cancer, 124 (5), 1016-1024
DOI 10.1002/cncr.31157, PubMed 29211298

Zeller B, Glosli H, Forestier E, Ha SY, Jahnukainen K, Jónsson ÓG, Lausen B, Palle J, Hasle H, Abrahamsson J, NOPHO AML working group (2017)
Hyperleucocytosis in paediatric acute myeloid leukaemia - the challenge of white blood cell counts above 200 × 109 /l. The NOPHO experience 1984-2014
Br J Haematol, 178 (3), 448-456
DOI 10.1111/bjh.14692, PubMed 28542715

Publications 2016

Ferrari A, Trama A, De Paoli A, Bergeron C, Merks JHM, Jenney M, Orbach D, Chisholm JC, Gallego S, Glosli H, De Salvo GL, Botta L, Gatta G, Bisogno G, RARECAREnet Working Group (2016)
Access to clinical trials for adolescents with soft tissue sarcomas: Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols
Pediatr Blood Cancer, 64 (6)
DOI 10.1002/pbc.26348, PubMed 27882658

Publications 2015

Jarfelt M, Andersen NH, Glosli H, Jahnukainen K, Jónmundsson GK, Malmros J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (NOPHO) (2015)
Cardiac function in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study
Eur J Haematol, 97 (1), 55-62
DOI 10.1111/ejh.12683, PubMed 26383901

Publications 2014

Skou AS, Glosli H, Jahnukainen K, Jarfelt M, Jónmundsson GK, Malmros-Svennilson J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (2014)
Renal, gastrointestinal, and hepatic late effects in survivors of childhood acute myeloid leukemia treated with chemotherapy only--a NOPHO-AML study
Pediatr Blood Cancer, 61 (9), 1638-43
DOI 10.1002/pbc.25069, PubMed 24760750

Publications 2013

Molgaard-Hansen L, Skou AS, Juul A, Glosli H, Jahnukainen K, Jarfelt M, Jónmundsson GK, Malmros J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (2013)
Pubertal development and fertility in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study
Pediatr Blood Cancer, 60 (12), 1988-95
DOI 10.1002/pbc.24715, PubMed 24038890

Publications 2011

Molgaard-Hansen L, Möttönen M, Glosli H, Jónmundsson GK, Abrahamsson J, Hasle H, Nordic Society of Paediatric Haematology and Oncology (NOPHO) (2011)
Treatment-related deaths in second complete remission in childhood acute myeloid leukaemia
Br J Haematol, 152 (5), 623-30
DOI 10.1111/j.1365-2141.2010.08554.x, PubMed 21241281

Publications 2010

Molgaard-Hansen L, Glosli H, Jahnukainen K, Jarfelt M, Jónmundsson GK, Malmros-Svennilson J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (2010)
Quality of health in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study
Pediatr Blood Cancer, 57 (7), 1222-9
DOI 10.1002/pbc.22931, PubMed 22095929

Molgaard-Hansen L, Möttönen M, Glosli H, Jónmundsson GK, Abrahamsson J, Hasle H, Nordic Society of Paediatric Haematology and Oncology (NOPHO) (2010)
Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003
Br J Haematol, 151 (5), 447-59
DOI 10.1111/j.1365-2141.2010.08389.x, PubMed 20955398

Publications 2008

Glosli H, Stray-Pedersen A, Brun AC, Holtmon LW, Tønjum T, Chapgier A, Casanova JL, Abrahamsen TG (2008)
Infections due to various atypical mycobacteria in a Norwegian multiplex family with dominant interferon-gamma receptor deficiency
Clin Infect Dis, 46 (3), e23-7
DOI 10.1086/525855, PubMed 18171304

Publications 2005

Glosli H, Gudbrandsen OA, Mullen AJ, Halvorsen B, Røst TH, Wergedahl H, Prydz H, Aukrust P, Berge RK (2005)
Down-regulated expression of PPARalpha target genes, reduced fatty acid oxidation and altered fatty acid composition in the liver of mice transgenic for hTNFalpha
Biochim Biophys Acta, 1734 (3), 235-46
DOI 10.1016/j.bbalip.2005.02.011, PubMed 15893958

Publications 2004

Glosli H, Prydz H, Roald B (2004)
Involution of thymus and lymphoid depletion in mice expressing the hTNF transgene
APMIS, 112 (1), 63-73
DOI 10.1111/j.1600-0463.2004.apm1120111.x, PubMed 14961977

Publications 2002

Glosli H, Tronstad KJ, Wergedal H, Müller F, Svardal A, Aukrust P, Berge RK, Prydz H (2002)
Human TNF-alpha in transgenic mice induces differential changes in redox status and glutathione-regulating enzymes
FASEB J, 16 (11), 1450-2
DOI 10.1096/fj.01-0948fje, PubMed 12205044

Publications 1999

Glosli H, Veiby OP, Fjerdingstad H, Mehlum A, Probert L, Kollias G, Gjernes E, Prydz H (1999)
Effects of hTNFalpha expression in T cells on haematopoiesis in transgenic mice
Eur J Haematol, 63 (1), 50-60
PubMed 10414455

Publications 1992

Dahl-Jørgensen K, Glosli H, Joner G, Rønningen KS, Søvik O (1992)
[Can type 1 diabetes be prevented?]
Tidsskr Nor Laegeforen, 112 (23), 2951-2
PubMed 1412340

Page visits: 1472